Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
635.5000 3.90 (0.62%)
NSE Oct 03, 2025 15:31 PM
Volume: 509.8K
 

635.50
0.62%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 17.5% YoY to | 274.5 crore (I-direct estimate: | 302.6 crore) mainly due to growth in the discovery services vertical and development and manufacturing group. Adjusting for the impact of sales return, growth would have been 22.5% EBITDA margins declined 120 bps to 32.3% YoY (I-direct estimate: 32.3%) owing to higher employee cost and other expenditure, which was partially offset by improvement in gross margins. EBITDA grew...
Syngene International Ltd. has lost -28.14% in the last 1 Year
More from Syngene International Ltd.
Recommended